Skip to main content
SDEV logo

SDEV · Stablecoin Development Corp

$1.12 -0.01 (-0.45%)
Market Cap
$30.37M
Shares
27.12M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$9.78M -6.4%
FY2024 Revenue FY2009–FY2024
Net Income
-$630.78M -8632.9%
FY2025 Net Income FY2009–FY2025
Gross Margin
66.26% +8.1pp
FY2024 Gross Margin FY2012–FY2024
Operating Margin
-75.44% -36.2pp
FY2024 Operating Margin FY2009–FY2024
Diluted EPS
-$1,898.75 +35.4%
FY2020 Diluted EPS FY2009–FY2020
Operating Cash Flow
-$8.43M -12.4%
FY2025 Operating Cash Flow FY2009–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009
$9.78M $10.46M $14.4M $10.2M $9.93M $6.6M $12.51M $18.23M $11.9M $4.38M $370K $3.25M $6.93M $11.02M $9.75M $15.68M
$3.3M $4.37M $6.62M $3.69M $3.97M $1.74M $1.5M $2.78M $2.46M $1.26M $486K $162K $8000
$6.48M $6.08M $7.78M $6.52M $5.96M $4.86M $11.01M $15.45M $9.43M $3.12M $568K $3.32M $6000
66.26% 58.19% 54.02% 63.85% 60.04% 73.66% 87.98% 84.73% 79.29% 71.22% 153.51% 101.87% 0.09%
$42K $34K $174K $44K $285K $184K $259K $410K $1.37M $5.73M $9.48M $12.46M $9.28M $9.91M $8.62M $7.34M
$4.03M $4.71M $7.8M $8.09M $6.17M $8.77M $12.79M $13.71M $11.81M $10.52M $1.75M
$7.73M $7.59M $7.38M $5.45M $7.49M $7.24M $5.93M $5.31M $5.83M $8.64M $7.24M $8.01M $6.24M $45.97M $5.97M $5.43M $5.65M $5.61M
$18.09M $7.94M $6.34M $5.97M
$152K $152K $363K $60K
$51K $120K $59K $51K $65K $266K $95K $114K $164K $232K $314K $341K $425K $427K $373K
$8M $8.44M $7.38M $10.19M $22.2M $15.38M $12.39M $14.26M $18.88M $22.76M $20.42M $24.26M $17.47M $18.8M $15.25M $15.34M $14.27M $12.94M
$17.14M -$8.44M -$7.38M -$4.1M -$14.42M -$8.86M -$6.43M -$9.4M -$7.87M -$7.31M -$10.98M -$21.14M -$16.9M -$15.49M -$8.31M -$4.32M -$4.52M $2.74M
-75.44% -39.23% -100.09% -86.85% -64.69% -142.45% -62.93% -40.1% -92.31% -482.47% -4568.65% -475.91% -119.85% -39.21% -46.3% 17.47%
-$4.05M -$14.3M -$8.8M -$6.38M -$9.34M -$7.61M -$7.22M -$10.87M -$20.97M -$16.67M -$15.17M -$7.97M -$3.9M -$4.09M $3.11M
$533.59M -$20K -$581K -$369K -$276K -$1.58M $605K -$1.43M $19K $12K -$68K $17K $48K $1000 -$155K -$30K $258K -$36K
-$9.64M -$10.61M -$5.82M -$11.03M -$9.65M -$6.54M -$7.4M -$13.15M -$18.97M -$15.19M -$16.04M -$7.03M -$5.08M -$4.26M $2.7M
$3.45M $0 $0 $0 $0 $0 $5000 $6000 $4000 $3000 $2000 $2000 $2000 $1600 $2000 $2000 $50K $7000
-$86.05M -$630.78M -$7.22M -$9.64M -$10.61M -$5.82M -$11.04M -$9.66M -$6.55M -$7.4M -$13.15M -$18.97M -$15.19M -$16.04M -$7.03M -$5.09M -$4.31M $2.7M
-73.85% -92.2% -73.65% -57.08% -111.12% -146.36% -52.33% -40.61% -110.54% -433.07% -4106.49% -492.99% -101.36% -46.15% -44.17% 17.2%
-$86.05M -$630.78M -$8.61M -$16.97M -$16.27M -$6.56M -$11.04M -$10.49M -$6.55M -$7.4M
-$13.15M -$18.97M -$15.18M -$16.04M -$7M -$5.12M -$4.32M
USD/shares -$108.39 -$12.68 -$695.70 -$1,767.50 -$920.50 -$1,898.75 -$2,940.00 -$2,388.75 -$2,940.00 -$8,575.00 -$41,772.50 -$46,856.25 -$64,373.75 -$1,470.00 -$1,225.00 -$1,102.50 $137,224,500.00
USD/shares -$1,898.75 -$2,940.00 -$2,817.50 -$2,940.00 -$8,575.00 -$41,772.50 -$46,856.25 -$64,373.75 -$1,470.00 -$1,225.00 -$1,102.50 $141,579,375.00
shares 5.82M 679K 24K 9200 7125.7143 5726.6939 3533.2245 2762.6122 2501.8776 1536 454.5306 324.0816 249.3061 4807.8367 4207.8367 3808.3265
shares 7127.6735 5726.6939 3533.2245 2784.9796 2501.8776 1536 454.5306 324.0816 249.3061 4807.8367 4207.8367 3808.3265 0.0196
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2018–FY2025: $4.82M in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
EV/EBIT
P/E (TTM)
Peer median 8.32×

Peer medians compare against the 42 similar-size Asset Management companies (of 108 listed).

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2023 FY2022 FY2021
Optical and Wound Care $11,174,000 $10,239,000 $9,555,000
Skin Care $3,552,000 $4,165,000 $649,000

By Product & Service (USD)

Component FY2024 FY2024 FY2023 FY2023 FY2022 FY2021 FY2020 FY2019
Avenova Spray $8,673,000 $3,695,000 $7,805,000 $7,651,000 $8,565,000 $5,974,000 $6,347,000
Avenova Product $7,200,000 $6,100,000 $6,500,000
Other Products $1,074,000 $1,117,000 $1,273,000 $1,592,000 $598,000 $294,000 $0
Product And Service Other $34,000 $18,000 $0 $30,000 $24,000 $18,000 $43,000
Neutrophase $0 $1,043,000 $1,377,000 $976,000 $368,000 $524,000 $209,000
Avenova Direct $1,700,000 $6,500,000 $6,600,000 $3,300,000 $1,000,000
Dermadoctor $3,552,000 $4,155,000 $649,000 $0 $0
KN95 Masks $0 $3,124,000 $0

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2023 FY2022 FY2021
Optical and Wound Care -$3,650,000 -$5,645,000 -$8,682,000
Skin Care -$3,946,000 -$8,772,000 -$180,000

Operating Margin by Segment (%)

Component FY2023 FY2022 FY2021
Optical and Wound Care -32.7% -55.1% -90.9%
Skin Care -111.1% -210.6% -27.7%
Key facts CIK 1389545 CUSIP 66987P508 13F (30d) 6 filings 6 filers Visit website Investor relations